Assessment of the Necessity of Osteoporosis Treatment for Patients with Low Bone Density in Diffuse Idiopathic Skeletal Hyperostosis

Introduction: Although patients with diffuse idiopathic skeletal hyperostosis (DISH) do not have low bone density, it is a risk factor for spine fractures associated with DISH. We investigated the characteristics and bone metabolism markers of patients with DISH having low bone density to assess whe...

Full description

Bibliographic Details
Main Authors: Mitsuru Furukawa, Kunimasa Okuyama, Ken Ninomiya, Takeshi Miyamoto, Yoshiyuki Yato
Format: Article
Language:English
Published: The Japanese Society for Spine Surgery and Related Research 2022-09-01
Series:Spine Surgery and Related Research
Subjects:
Online Access:https://www.jstage.jst.go.jp/article/ssrr/6/5/6_2021-0149/_pdf/-char/en
_version_ 1811241641317498880
author Mitsuru Furukawa
Kunimasa Okuyama
Ken Ninomiya
Takeshi Miyamoto
Yoshiyuki Yato
author_facet Mitsuru Furukawa
Kunimasa Okuyama
Ken Ninomiya
Takeshi Miyamoto
Yoshiyuki Yato
author_sort Mitsuru Furukawa
collection DOAJ
description Introduction: Although patients with diffuse idiopathic skeletal hyperostosis (DISH) do not have low bone density, it is a risk factor for spine fractures associated with DISH. We investigated the characteristics and bone metabolism markers of patients with DISH having low bone density to assess whether osteoporosis medication is necessary to prevent fractures. Methods: A cross-sectional study was conducted between April 1, 2008, and March 31, 2019. The 86 patients included were divided into two groups according to their T-scores―one group had low bone density and DISH, and the other group did not. Group A (T-score−1) and B (T-score>−1) data were adjusted for confounding factors and compared for differences in age, body weight, maximum number of vertebral bodies with bony bridges between adjacent vertebrae (max VB), and previous history (hypertension, malignant tumors, diabetes mellitus, cardiac diseases, chronic renal failure, and spinal fractures). In Group A, multiple linear regression was used to investigate relationships among max VB, femur bone mineral density (BMD), total type I procollagen N-terminal propeptide (P1NP), and tartrate-resistant acid phosphatase 5b (TRACP-5b). Results: Group A had 36, and Group B had 50 male patients with DISH. Patients in Group B were heavier than those in Group A. The mean femur BMD in Group A was age-appropriate, and that in Group B was higher than the age-appropriate femur BMD. The mean values of P1NP and TRACP-5b were within the normal range. Max VB was positively correlated with total P1NP in Group A. Total P1NP was significantly and positively correlated with TRACP-5b. Conclusions: The DISH group with a T-score of −1 was age-appropriate. The group with a T-score of >−1 had higher BMD because of their higher body weight. The group with a T-score of −1 had good bone metabolism and did not require aggressive osteoporosis treatment.
first_indexed 2024-04-12T13:39:01Z
format Article
id doaj.art-7401dab1bfda41a2a032ed900cab72e2
institution Directory Open Access Journal
issn 2432-261X
language English
last_indexed 2024-04-12T13:39:01Z
publishDate 2022-09-01
publisher The Japanese Society for Spine Surgery and Related Research
record_format Article
series Spine Surgery and Related Research
spelling doaj.art-7401dab1bfda41a2a032ed900cab72e22022-12-22T03:30:54ZengThe Japanese Society for Spine Surgery and Related ResearchSpine Surgery and Related Research2432-261X2022-09-016552653210.22603/ssrr.2021-01492021-0149Assessment of the Necessity of Osteoporosis Treatment for Patients with Low Bone Density in Diffuse Idiopathic Skeletal HyperostosisMitsuru Furukawa0Kunimasa Okuyama1Ken Ninomiya2Takeshi Miyamoto3Yoshiyuki Yato4Department of Orthopedic Surgery, Murayama Medical CenterDepartment of Orthopedic Surgery, Shizuoka City Shimizu HospitalDepartment of Orthopedic Surgery, Shizuoka City Shimizu HospitalDepartment of Orthopedic Surgery, Kumamoto UniversityDepartment of Orthopedic Surgery, Murayama Medical CenterIntroduction: Although patients with diffuse idiopathic skeletal hyperostosis (DISH) do not have low bone density, it is a risk factor for spine fractures associated with DISH. We investigated the characteristics and bone metabolism markers of patients with DISH having low bone density to assess whether osteoporosis medication is necessary to prevent fractures. Methods: A cross-sectional study was conducted between April 1, 2008, and March 31, 2019. The 86 patients included were divided into two groups according to their T-scores―one group had low bone density and DISH, and the other group did not. Group A (T-score−1) and B (T-score>−1) data were adjusted for confounding factors and compared for differences in age, body weight, maximum number of vertebral bodies with bony bridges between adjacent vertebrae (max VB), and previous history (hypertension, malignant tumors, diabetes mellitus, cardiac diseases, chronic renal failure, and spinal fractures). In Group A, multiple linear regression was used to investigate relationships among max VB, femur bone mineral density (BMD), total type I procollagen N-terminal propeptide (P1NP), and tartrate-resistant acid phosphatase 5b (TRACP-5b). Results: Group A had 36, and Group B had 50 male patients with DISH. Patients in Group B were heavier than those in Group A. The mean femur BMD in Group A was age-appropriate, and that in Group B was higher than the age-appropriate femur BMD. The mean values of P1NP and TRACP-5b were within the normal range. Max VB was positively correlated with total P1NP in Group A. Total P1NP was significantly and positively correlated with TRACP-5b. Conclusions: The DISH group with a T-score of −1 was age-appropriate. The group with a T-score of >−1 had higher BMD because of their higher body weight. The group with a T-score of −1 had good bone metabolism and did not require aggressive osteoporosis treatment.https://www.jstage.jst.go.jp/article/ssrr/6/5/6_2021-0149/_pdf/-char/enbone mineral densitydiffuse idiopathic skeletal hyperostosisproximal femurtype i procollagen n-terminal propeptide
spellingShingle Mitsuru Furukawa
Kunimasa Okuyama
Ken Ninomiya
Takeshi Miyamoto
Yoshiyuki Yato
Assessment of the Necessity of Osteoporosis Treatment for Patients with Low Bone Density in Diffuse Idiopathic Skeletal Hyperostosis
Spine Surgery and Related Research
bone mineral density
diffuse idiopathic skeletal hyperostosis
proximal femur
type i procollagen n-terminal propeptide
title Assessment of the Necessity of Osteoporosis Treatment for Patients with Low Bone Density in Diffuse Idiopathic Skeletal Hyperostosis
title_full Assessment of the Necessity of Osteoporosis Treatment for Patients with Low Bone Density in Diffuse Idiopathic Skeletal Hyperostosis
title_fullStr Assessment of the Necessity of Osteoporosis Treatment for Patients with Low Bone Density in Diffuse Idiopathic Skeletal Hyperostosis
title_full_unstemmed Assessment of the Necessity of Osteoporosis Treatment for Patients with Low Bone Density in Diffuse Idiopathic Skeletal Hyperostosis
title_short Assessment of the Necessity of Osteoporosis Treatment for Patients with Low Bone Density in Diffuse Idiopathic Skeletal Hyperostosis
title_sort assessment of the necessity of osteoporosis treatment for patients with low bone density in diffuse idiopathic skeletal hyperostosis
topic bone mineral density
diffuse idiopathic skeletal hyperostosis
proximal femur
type i procollagen n-terminal propeptide
url https://www.jstage.jst.go.jp/article/ssrr/6/5/6_2021-0149/_pdf/-char/en
work_keys_str_mv AT mitsurufurukawa assessmentofthenecessityofosteoporosistreatmentforpatientswithlowbonedensityindiffuseidiopathicskeletalhyperostosis
AT kunimasaokuyama assessmentofthenecessityofosteoporosistreatmentforpatientswithlowbonedensityindiffuseidiopathicskeletalhyperostosis
AT kenninomiya assessmentofthenecessityofosteoporosistreatmentforpatientswithlowbonedensityindiffuseidiopathicskeletalhyperostosis
AT takeshimiyamoto assessmentofthenecessityofosteoporosistreatmentforpatientswithlowbonedensityindiffuseidiopathicskeletalhyperostosis
AT yoshiyukiyato assessmentofthenecessityofosteoporosistreatmentforpatientswithlowbonedensityindiffuseidiopathicskeletalhyperostosis